Vaccine Preventable Disease and Vaccine Hesitancy

Area of Science:

• Vaccinology
• Infectious Diseases
• Public Health

Background:

• Global immunization programs have significantly reduced mortality over the past two decades.
• The recent success of COVID-19 vaccines highlights the potential of rapid vaccine development and deployment.

Purpose of the Study:

• To explore the potential acceleration of vaccine technologies for emerging infections.
• To identify new vaccines advancing in clinical development.
• To discuss the implications for future public health initiatives.

Main Methods:

• Review of current vaccine development pipelines.
• Analysis of the impact of recent vaccine successes.
• Synthesis of information on emerging infectious disease threats.

Main Results:

• Numerous vaccines for respiratory syncytial virus, norovirus, influenza, herpes simplex virus, shingles, dengue fever, enteric bacterial infections, malaria, and Chagas disease are in late-stage clinical development.
• These vaccines are anticipated to be available within the next five years.
• COVID-19 vaccine success may catalyze faster development for other infectious diseases.

Conclusions:

• The pipeline for new vaccines against various infectious diseases is robust.
• Successful deployment of these upcoming vaccines will necessitate enhanced advocacy and communication strategies.
• Continued investment in vaccine technology is crucial for global health security.